- Home
- / Balaxi Pharmaceuticals
Balaxi Pharmaceuticals
Stock Price
₹89.8
2024-10-29
Market Capitalization
₹4.6 B
2024-10-29
Revenue
₹2.9 B
FY, 2025
Balaxi Pharmaceuticals Summary
Company Summary
- Overview
- Balaxi Pharmaceuticals is a company that manufactures pharmaceutical and Fast-moving consumer goods (FCMG) products. It offers salt biscuits, cream-filled biscuits, generic medicines, oral healthcare products, etc.
- Type
- Public
- Status
- Active
- Founded
- 2004
- Website
- http://www.balaxiventures.in
- Cybersecurity rating
- Sectors
Table of Contents
Balaxi Pharmaceuticals Financials
Summary Financials
- Revenue (Q3, 2026)
- ₹725.4M
- Gross profit (Q3, 2026)
- ₹309.0M
- Net income (Q3, 2026)
- ₹3.1M
- Cash (Q2, 2026)
- ₹388.5M
- EBIT (Q3, 2026)
- ₹26.3M
- Enterprise value
- $4.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026